Group One Trading
XFOR icon

Group One Trading’s X4 Pharmaceuticals XFOR Stock Holding History

Group One Trading’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.94K Sell
712
-3,286
-82% -$12.3K ﹤0.01% 6931
2025
Q4 		$16K Hold
3,998
– – ﹤0.01% 6525
2025
Q3 		$13.7K Hold
3,998
– – ﹤0.01% 6976
2025
Q2 		$7.6K Sell
3,998
-1,739
-30% -$7.12K ﹤0.01% 6886
2025
Q1 		$40.7K Sell
5,737
-20,843
-78% -$287K ﹤0.01% 5313
2024
Q4 		$585K Buy
26,580
+22,397
+535% +$357K ﹤0.01% 3043
2024
Q3 		$84K Sell
4,183
-1,292
-24% -$27K ﹤0.01% 4312
2024
Q2 		$95.3K Buy
5,475
+4,767
+673% +$156K ﹤0.01% 4005
2024
Q1 		$29.5K Sell
708
-1,651
-70% -$45.9K ﹤0.01% 5133
2023
Q4 		$59.3K Sell
2,359
-5,186
-69% -$126K ﹤0.01% 4922
2023
Q3 		$247K Sell
7,545
-3,319
-31% -$145K ﹤0.01% 3624
2023
Q2 		$632K Buy
10,864
+9,854
+976% +$506K ﹤0.01% 2789
2023
Q1 		$26.4K Buy
1,010
+337
+50% +$9.88K ﹤0.01% 5330
2022
Q4 		$20K Sell
673
-423
-39% -$20K ﹤0.01% 5595
2022
Q3 		$56K Buy
+1,096
New +$37.9K ﹤0.01% 5314
2022
Q2 		– Sell
-565
Closed -$21.5K – 8630
2022
Q1 		$30K Buy
565
+107
+23% +$6.14K ﹤0.01% 6484
2021
Q4 		$31K Buy
458
+389
+564% +$49.2K ﹤0.01% 6711
2021
Q3 		$11K Buy
+69
New +$11.4K ﹤0.01% 7471

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Group One Trading's XFOR Position: Q1 2026 in Review

Group One Trading reduced its X4 Pharmaceuticals (XFOR) stake by 82% in Q1 2026, selling an estimated $12.3K and leaving 712 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #6931.

Group One Trading first reported a position in XFOR in Q3 2021 and has held it in 18 quarters since. The position peaked at $632K in Q2 2023. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • Group One Trading held 712 shares of X4 Pharmaceuticals worth $2.94K as of Q1 2026.
  • Group One Trading sold 3,286 X4 Pharmaceuticals shares in Q1 2026, an estimated $12.3K.
  • X4 Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6931 holding.
  • Group One Trading first reported a position in X4 Pharmaceuticals in Q3 2021 and has held it in 18 quarters since.
  • Group One Trading's X4 Pharmaceuticals position peaked at $632K in Q2 2023.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.